Tuberculosis Global Clinical Trials Review, Q4, 2010
Our clinical trial report, “Tuberculosis Global Global Clinical Trials Review, Q4, 2010"” provides data on the Tuberculosis clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Tuberculosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Tuberculosis.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrollment pattern by phase for the past decade
- Number of clinical trials segmented by key drugs
- Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
- Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy
- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies SHOW LESS READ MORE >
List of Tables
List of Figures
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Tuberculosis
Subjects Recruited Over a Period of Time
Top Companies Participating in Tuberculosis Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Clinical Trial Overview of GlaxoSmithKline plc
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Clinical Trial Overview of Pfizer Inc.
Otsuka Pharmaceutical Co., Ltd.
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd.
Clinical Trial Overview of Vakzine Projekt Management GmbH
Global Alliance for TB Drug Development
Clinical Trial Overview of Global Alliance for TB Drug Development
Clinical Trial Overview of Abbott Laboratories
Clinical Trial Overview of Archivel Farma S.L.
RIEMSER Arzneimittel AG
Clinical Trial Overview of RIEMSER Arzneimittel AG
Clinical Trial Overview of Novartis AG